The present invention relates to non-invasive ventilation and pressure support systems wherein a patient interface device is used to deliver a flow of breathing gas to a patient and, more particularly, sealing elements for providing a seal between patient interface devices and subjects using such devices.
There are numerous situations where it is necessary or desirable to deliver a flow of breathing gas non-invasively to the airway of a patient, i.e., without intubating the patient or surgically inserting a tracheal tube in their esophagus. For example, it is known to ventilate a patient using a technique known as non-invasive ventilation. It is also known to deliver positive airway pressure (PAP) therapy to treat certain medical disorders, the most notable of which is obstructive sleep apnea (OSA). Known PAP therapies include continuous positive airway pressure (CPAP), wherein a constant positive pressure is provided to the airway of the patient in order to splint open the patient's airway, and variable airway pressure, wherein the pressure provided to the airway of the patient is varied with the patient's respiratory cycle. Such therapies are typically provided to the patient at night while the patient is sleeping.
Non-invasive ventilation and pressure support therapies as just described involve a gas flow generator to produce a flow of breathing gas, and the placement of a patient interface device including a mask component on the face of a patient. The gas flow generator produces positive air pressure by taking air in from the surroundings and spinning a fan to push the air out of the machine, through a delivery conduit, and into the patient interface device to be delivered to the patient.
Traditional cushion members for patient interface devices include a sealing portion that is structured to engage the face of the patient in order to provide a seal therewith. Known sealing portions suffer from a number of drawbacks, such as applying too much pressure to certain areas of the face, resulting in red marks and a less than ideal fit. Another major problem is leaks. Stick-to-face adhesive masks could solve leaks, but in order to be reimbursable, cushions need to last for thirty days. It is difficult to create a stick-to face adhesive that works well for 30 days despite numerous reapplications and washings.
Furthermore, OSA patients tend to suffer from numerous comorbidities, some of which (e.g., hypertension (35% of OSA patients), diabetes mellitus type II (15% of OSA patients), depression (19% of OSA patients, etc.) are treatable by medication administered transdermally. Current CPAP masks do not provide for a secondary benefit, other than the increased health provided by CPAP therapy.
Accordingly, it is an object of the present invention to provide an improved sealing arrangement for use in delivering a flow of a breathing gas to the airway of a patient.
As one aspect of the invention, such a sealing arrangement comprises: a base structure having a surface positioned to engage the face of the patient, the base structure defining an opening having a perimeter, the perimeter being sized and configured to be disposed about one or more of the mouth and/or nares of the patient; and a secondary element coupled to the base structure, the secondary element being positioned and structured to contact the face of the patient when the base structure is disposed with the perimeter about the one or more of the mouth and/or nares of the patient, wherein the base structure is formed from a first material, and wherein the secondary element is formed from a second material different than the first material.
The base structure may comprise a sealing flap of a cushion member of a patient interface device. The perimeter may be sized and configured to be disposed about both the mouth and the nares of the patient. The perimeter may be sized and configured to be disposed about only the nares of the patient. The base structure may comprise a nasal cushion. The second material may comprise a tacky material structured to adhere to the patient. The second material may comprise a transdermal drug delivery arrangement. The second material may comprise a material having a predetermined scent. The base structure may comprise a groove defined in the surface positioned to engage the face of the patient, and the secondary element may be coupled in the groove. The secondary element may be mechanically coupled in the groove. The secondary element may be coupled in the groove via a press-fit. The secondary element may be coupled in the groove via an adhesive. The secondary element may comprise a patient contacting surface, and the patient contacting surface may be flush with the surface of the base structure that is positioned to engage the face of the patient. The groove may extend entirely around the opening defined by the base structure. The groove may extend along only a portion of the perimeter. The secondary element may be coupled to the base structure via an adhesive. The secondary element may be coupled to the base structure via a mechanical coupling. The base structure may be overmolded onto the secondary element. The secondary element may be molded in the base structure. The secondary element may extend entirely around the opening defined by the base structure. The secondary element may extends along only a portion of the perimeter.
As another aspect of the invention, a secondary element for use with a base structure in a sealing arrangement for use in delivering a flow of breathing gas to an airway of a patient is provided. The secondary element comprises: a thin, elongate contoured member sized and configured to be disposed in a groove defined in a contoured patient contacting surface of the base structure.
The contoured member may comprise: a first contoured surface positioned to contact the patient and a second contoured surface disposed opposite the first surface; and an adhesive disposed on the second contoured surface. The contoured member may comprise a tacky material structured to adhere to the patient. The contoured member may comprise a transdermal drug delivery arrangement.
These and other objects, features, and characteristics of the present invention, as well as the methods of operation and functions of the related elements of structure and the combination of parts and economies of manufacture, will become more apparent upon consideration of the following description and the appended claims with reference to the accompanying drawings, all of which form a part of this specification, wherein like reference numerals designate corresponding parts in the various figures. It is to be expressly understood, however, that the drawings are for the purpose of illustration and description only and are not intended as a definition of the limits of the invention.
As used herein, the singular form of “a”, “an”, and “the” include plural references unless the context clearly dictates otherwise. As used herein, the statement that two or more parts or components are “coupled” shall mean that the parts are joined or operate together either directly or indirectly, i.e., through one or more intermediate parts or components, so long as a link occurs. As used herein, “directly coupled” means that two elements are coupled directly in contact with each other (i.e., touching). As used herein, “fixedly coupled” or “fixed” means that two components are coupled so as to move as one while maintaining a constant orientation relative to each other.
As employed herein, the statement that two or more parts or components “engage” one another shall mean that the parts exert a force against one another either directly or through one or more intermediate parts or components. As employed herein, the term “number” shall mean one or an integer greater than one (i.e., a plurality). Directional phrases used herein, such as, for example and without limitation, left, right, upper, lower, front, back, on top of, and derivatives thereof, relate to the orientation of the elements shown in the drawings and are not limiting upon the claims unless expressly recited therein. As employed herein, the term “and/or” shall mean one or both of the elements separated by such term. For example, “A and/or B” would mean any of: i) A, ii) B, or iii) A and B.
As used herein, the phrase “mechanical bond” shall mean a bond formed as a result of the curing (i.e., solidifying) of a material selected from the group consisting of a monomer, a polymer, and a mixture of a monomer and a polymer (e.g., without limitation, silicone) to a fabric material. For example, without limitation, a bond formed when a viscous silicone material flows into fibers of a fabric material and is thereafter cured is a mechanical bond. A connection formed when a fabric material is stitched to a silicone material is not a mechanical bond.
As used herein, the phrase “chemical bond” shall mean a bond formed as a result of the curing (i.e., solidifying) of a first material to a second material, where each of the first and second materials is made of a monomer, a polymer, or a mixture of a monomer and a polymer.
A system 2 adapted to provide a regimen of respiratory therapy to a patient according to one exemplary embodiment of the invention is generally shown in
A BiPAP® device is a bi-level device in which the pressure provided to the patient varies with the patient's respiratory cycle, so that a higher pressure is delivered during inspiration than during expiration. An auto-titration pressure support system is a system in which the pressure varies with the condition of the patient, such as whether the patient is snoring or experiencing an apnea or hypopnea. For present purposes, flow/pressure generating device 4 is also referred to as a gas flow generating device, because flow results when a pressure gradient is generated. The present invention contemplates that flow/pressure generating device 4 is any conventional system for delivering a flow of gas to an airway of a patient or for elevating a pressure of gas at an airway of the patient, including the pressure support systems summarized above and non-invasive ventilation systems.
In the exemplary embodiment illustrated in
Cushion 14 may be formed of any pliable material (e.g., without limitation, silicone). Frame 16 may be formed of a substantially rigid material (e.g., without limitation, one or more plastics). Although frame 16 is shown having a forehead support 18, frame 16 is provided for exemplary purposes only and is not intended to be limiting upon the present invention as embodiments of the present invention are applicable to interface devices including various frame types as well as interface devices which do not utilize any frame.
Referring to
Continuing to refer to
Secondary element 30 is formed as a thin (example embodiments are generally in the range of about 0.2 mm to about 2 mm), elongate contoured member having a first contoured surface 32 positioned to contact the patient and a second contoured surface 34 disposed opposite the first surface. In the example illustrated in
In the example embodiment illustrated in
As shown in
It is to be appreciated that in addition to the coupling arrangements between base structure 22 and secondary element 30 previously discussed, other coupling arrangements may be employed without varying from the scope of the present invention. For example, for a more permanent arrangement, base structure 22 may be overmolded onto secondary element 30. Alternatively, secondary element 30 may be molded in base structure 22.
In the claims, any reference signs placed between parentheses shall not be construed as limiting the claim. The word “comprising” or “including” does not exclude the presence of elements or steps other than those listed in a claim. In a device claim enumerating several means, several of these means may be embodied by one and the same item of hardware. The word “a” or “an” preceding an element does not exclude the presence of a plurality of such elements. In any device claim enumerating several means, several of these means may be embodied by one and the same item of hardware. The mere fact that certain elements are recited in mutually different dependent claims does not indicate that these elements cannot be used in combination.
Although the invention has been described in detail for the purpose of illustration based on what is currently considered to be the most practical and preferred embodiments, it is to be understood that such detail is solely for that purpose and that the invention is not limited to the disclosed embodiments, but, on the contrary, is intended to cover modifications and equivalent arrangements that are within the spirit and scope of the appended claims. For example, it is to be understood that the present invention contemplates that, to the extent possible, one or more features of any embodiment can be combined with one or more features of any other embodiment.
This patent application claims the priority benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application No. 62/783,230, filed on Dec. 21, 2018, and 62/787,551 filed on Jan. 2, 2019, the contents of each which are herein incorporated by reference.
Number | Date | Country | |
---|---|---|---|
62787551 | Jan 2019 | US | |
62783230 | Dec 2018 | US |